Xlife Sciences AG (XLS)

Currency in CHF
16.00
-0.10(-0.62%)
Delayed Data·
Advertisement
XLS is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
16.0016.55
52 wk Range
15.7526.80
Key Statistics
Bid/Ask
16.00 / 16.35
Prev. Close
16.1
Open
16.05
Day's Range
16-16.55
52 wk Range
15.75-26.8
Volume
5.62K
Average Volume (3m)
8.22K
1-Year Change
-30.4348%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
XLS Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
31.00
Upside
+93.75%
Members' Sentiments
Bearish
Bullish
ProTips
Suffers from weak gross profit margins

Xlife Sciences AG News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

Analyst Ratings

1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 31.00
(+93.75% Upside)

Earnings

Latest Release
28/04/2026
EPS / Forecast
-3.23 / --
Revenue / Forecast
-79.01K / --
EPS Revisions
Last 90 days

Compare XLS to Peers and Sector

Metrics to compare
XLS
Peers
Sector
Relationship
P/E Ratio
−4.3x14.0x−0.4x
PEG Ratio
0.020.020.00
Price/Book
0.3x4.6x2.6x
Price / LTM Sales
333.5x3.9x3.0x
Upside (Analyst Target)
92.5%8.1%51.9%
Fair Value Upside
Unlock−9.1%7.2%Unlock

Xlife Sciences AG focuses on the development and commercialization of research projects in the life sciences sector. The company’s project covers technology platforms, biotechnology/therapies, medical technology, and artificial intelligence/digital health areas that focuses on identifying new therapeutic approaches and biomarkers for common diseases based on human genetic data; and offers clinical research services. It also develops novel treatment options in specific indication areas; focuses in the areas of medical technology to develop innovative methods for diagnosing illnesses and/or patient monitoring; and deploys artificial intelligence to improve diagnostic methods and/or processes in the field of biotechnology. Xlife Sciences AG was founded in 2019 and is headquartered in Zurich, Switzerland.

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
104.75K1.84%1.71M
Other Institutional Investors
0.000.00%0.00
Public Companies & Retail Investors
5.60M98.16%91.52M
Total
5.7M100.00%93.23M

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
DEVK Asset Management GmbH0.79%45,000736
Monega Rohstoffe0.79%45,000736

People Also Watch

6.90
CNTL
+7.48%
25.30
GLKBN
+0.40%
17.05
MIKN
-0.29%
6.10
MCHN
-0.33%

FAQ

What Is the Xlife Sciences (Switzerland: XLS) Share Price Today?

The Xlife Sciences stock price today is 16.00 CHF.

What Stock Exchange Does Xlife Sciences (XLS) Trade On?

Xlife Sciences is listed and trades on the Switzerland Stock Exchange.

What Is the Ticker (Stock Symbol) for Xlife Sciences?

The stock symbol (also called a 'ticker') for Xlife Sciences is "XLS."

What Is the Current Xlife Sciences Market Capitalisation?

As of today, Xlife Sciences (Switzerland: XLS) market cap is 91.81M CHF.

What Is Xlife Sciences's (XLS) Earnings Per Share (TTM)?

The Xlife Sciences EPS is currently -3.76 (Trailing Twelve Months).

Is XLS a Buy or Sell From a Technical Analyst Perspective?

Based on today's Xlife Sciences moving averages and other technical indicators, the daily buy/sell signal for XLS stock is Strong Sell.

How Many Times Has Xlife Sciences Stock Split?

Xlife Sciences has split 0 times. (See the XLS stock split history page for full effective split date and price information.)

How Many Employees Does Xlife Sciences Have?

Xlife Sciences has 20 employees, based on their latest Companies House report.

What is the current trading status of Xlife Sciences (Switzerland: XLS)?

As of 05/08/2026, Xlife Sciences (XLS) is trading at a share price of 16.00 CHF, with a previous close of 16.10 CHF. The stock has fluctuated within a day range of 16.00 CHF to 16.55 CHF, while its 52-week range spans from 15.75 CHF to 26.80 CHF.

What Is Xlife Sciences (XLS) Price Target According to Analysts?

The average 12-month price target for Xlife Sciences is 31.00 CHF, with a high estimate of 31 CHF and a low estimate of 31 CHF. 1 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +93.75% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.